Navigation Links
Crystalens HD(TM) Receives FDA Approval
Date:6/30/2008

Newest Version of the Only FDA Approved Accommodating Lens Designed to

Further Improve Near Vision

ALISO VIEJO, Calif., June 30 /PRNewswire/ -- Bausch & Lomb announced today that it has received approval from the Food and Drug Administration (FDA) to market the Crystalens HD(TM) in the United States. Crystalens accommodating intraocular lens (IOL) was first approved by the FDA in November 2003. The Crystalens HD is the fourth generation of the only FDA approved accommodating lens.

The surface of the Crystalens HD has been shaped to enhance the depth of focus with a proprietary optical modification. The enhanced optic provides an increased depth of focus which is designed to improve near vision without compromising intermediate or distance vision. The HD lens does this without inducing increased undesirable dysphotopsia or night vision symptoms.

A total of 125 primary eyes were implanted with the Crystalens HD in patients who had a visually significant cataract, less than 1 diopter of corneal astigmatism, and the potential for best corrected visual acuity (BCVA) of 20/25 or better in both eyes. Of these patients, 80% reported vision at J2 or better at four (4) months.

"Extensive market research has clearly indicated that patients and surgeons alike are asking for a truly accommodating IOL as their choice of lens. With these results, where patients reported getting one more line of near vision, we are coming ever closer to meeting the desired need for an optic that does provide truly good near vision without compromising the quality of vision at intermediate or distance," said Michael Judy, Chief Marketing Officer at Bausch & Lomb Surgical.

Dr. John Hovanesian was a Principal Investigator in the FDA study. Dr. Hovanesian serves as Clinical Instructor at the Jules Stein Eye Institute, UCLA in California and is in private practice at Harvard Eye Associates in Laguna Hills, California.

"If I were a
'/>"/>

SOURCE Bausch & Lomb
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. GSW Worldwide Named Agency of Record for BioBehavioral Diagnostics Companys MMAT/ADHD(TM) System
2. Weight Watchers Receives Adverse U.K. VAT Ruling
3. Instrumentation Laboratory Receives Performance Award from Premier for Second Consecutive Year
4. Labopharm Receives Response from FDA Regarding its Once-Daily Tramadol Product
5. Quark Pharmaceuticals Receives FDA Approval of IND for Kidney Transplant siRNA Drug DGFi
6. Preshaw receives Young Investigator Award
7. Childers receives research in Oral Biology Award
8. Melvin receives Salivary Research Award
9. Fischman receives Pharmacology/Therapeutics/Toxicology Research Award
10. Atchison receives Behavioral, Epidemiological and Health Services Research Award
11. Derma Sciences Receives FDA Clearance to Sell MEDIHONEY(TM) Over the Counter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... ... September 04, 2015 , ... Having access to a doctor can sometimes ... increasing amount of unnecessary emergency room visits which affects hospitals’ abilities to provide quality ... bill. Fortunately, a solution to alleviate this problem has recently presented itself, the new ...
(Date:9/4/2015)... DC (PRWEB) , ... September 04, 2015 , ... ... they all pale in comparison to settlements under the Stark physician self-referral law. ... an upcoming Sept. 17 webinar from Atlantic Information Services, Inc. (AIS), will detail ...
(Date:9/4/2015)... ... 2015 , ... Friday night, Chicago lovebirds Jenny McCarthy and Donnie Wahlberg celebrated ... event supporting families affected by autism, raising nearly $250,000. , 150 guests, including ... the Oscar Swan Inn to support the cause. , McCarthy tugged the heartstrings ...
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... TransPack Toon ... Users can choose from wipes and framing transitions in 30 different styles. Presets ... exclusively for Final Cut Pro X. , TransPack Toon features 90 cartoon transitions from ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... Inc., a leading national healthcare solutions organization, to provide electronic medical record (EMR) ... this agreement, Amerinet members will receive negotiated pricing on E-Volve Health’s Epic EMR ...
Breaking Medicine News(10 mins):Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 2Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 3Health News:Sept. 17 Webinar to Offer Best Practices for Physician Contracts 2Health News:Jenny McCarthy & Donnie Wahlberg Help Raise Over $200,000 For Generation Rescue’s ‘Night Of Hope’ Chicago Charity Event 2Health News:Pixel Film Studios Releases TransPack Toon, a New FCPX Transition 2Health News:E-Volve Health to Offer EMR Consulting Solutions to Amerinet Members 2
... Shire was the foremost patch medication approved to treat ... of methylphenidate - DAYTRANA, is now available in pharmacies ... 20 mg and 30 mg. ,'The availability of DAYTRANA, ... and parents with a new, practical way to individualize ...
... 2 chromosomes located at 1p and 19q predicted the prognosis ... J. Curran Jr., M.D., professor and chair of radiation oncology ... have found a paradigm shift in managing rare, malignant but ... last week in the Journal of Clinical Oncology, Dr. Curran ...
... The Gay Men’s Health Survey (GMHS) has identified that recently a ... HIV experience unemployment//. ,It also shows that about 50% ... forced to engage in sexual activity against their will. It was ... 20 to 40 were tested positive for HIV. The result ...
... Smith Glaxo Kline has found to be effective in preventing ... viruses (HPVs). ,Researchers suggested that HPV vaccination ... of the subjects. ,In the past 20 years, ... the discovery of the link between HPV and cervical cancer. ...
... dieting have shifted to high-fat and low-carbohydrate level.Researchers at ... of Colorado have noticed from the National Weight Control ... diet have increased over the past decade, while without ... National Weight Control Registry is a national study, tracking ...
... Celiac disease sufferers often endure a life of dietary restrictions, ... eaten foods//, ever passes their lips. ,But this may ... found that an enzyme originally developed for commercial food processing ... in the stomach before it reaches the small intestine. This ...
Cached Medicine News:Health News:Shire Developed DAYTRANA – The First Medication to Treat ADHD Symptom 2Health News:Shire Developed DAYTRANA – The First Medication to Treat ADHD Symptom 3Health News:Shire Developed DAYTRANA – The First Medication to Treat ADHD Symptom 4Health News:Missing Chromosomes Revealed Brain Tumor Therapy Effect – Research Find 2Health News:Missing Chromosomes Revealed Brain Tumor Therapy Effect – Research Find 3Health News:Dieting Behaviors Changed Among Weight Losers 2Health News:Dieting Behaviors Changed Among Weight Losers 3Health News:Celiac Disease Sufferers See an End to their Misery 2
(Date:9/3/2015)... , Sept. 3, 2015 ... Potentials of New Drugs, Industry Changes and Emerging ... the human ovaries? Visiongain,s new study forecasts those ... growth in that industry. You also explore trends, ... Our report gives revenue predictions to 2025 ...
(Date:9/3/2015)... NEW YORK , Sept. 3, 2015 /PRNewswire/ ... blood glucose device is a home-based electronic device. ... transmitter that transmits information about glucose levels through ... it is displayed. The regular usage of self-monitoring ... and prompt an individual to undergo proper diabetes ...
(Date:9/3/2015)... Sept. 3, 2015 Nevro Corp. (NYSE: ... providing innovative evidence-based solutions for the treatment of chronic ... at the Morgan Stanley Global Healthcare Conference on Thursday, ... Nevro management is scheduled to present at 11:45 ... live audio webcast, accessible in the "Investors" section of ...
Breaking Medicine Technology:Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 2Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 3Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 4Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 5Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 6Global Self-monitoring Blood Glucose Devices Market 2015-2019 2
... Karmanos Cancer,Institute physician-scientists today reported on two ... cancer at the American Association of Cancer ... Caucasian patients with endometrial or ovarian cancer, ... counterparts. Led,by Veronica Schimp, D.O., assistant professor ...
... Tanespimycin Shown to Have No Effect on QTc ... Kosan,Biosciences Incorporated today presented safety data from,preclinical and ... Serial electrocardiogram (ECG) monitoring,of patients was conducted in ... were conducted in more than 85,patients. Tanespimycin was ...
Cached Medicine Technology:Karmanos Physician-Scientists Examine Racial Disparities in,Patients with Gynecologic Cancer 2Karmanos Physician-Scientists Examine Racial Disparities in,Patients with Gynecologic Cancer 3Kosan Presents Data on Cardiac Safety Profile of Hsp90 Inhibitor,Tanespimycin (KOS-953) at AACR 2Kosan Presents Data on Cardiac Safety Profile of Hsp90 Inhibitor,Tanespimycin (KOS-953) at AACR 3Kosan Presents Data on Cardiac Safety Profile of Hsp90 Inhibitor,Tanespimycin (KOS-953) at AACR 4
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: